Table 2: The mean platelet count and their morphological parameters in patients suffering from gastric cancer—early gastric cancer, E (E1 before surgery, E2 after surgery), advanced cancer with metastasis to lymph nodes, A (A1 before surgery, A2 after surgery), and metastatic tumor, M (M1 before surgery, M2 after surgery) and in normal donors (C).

PLT MPV LPLT
X ± SDX ± SDX ± SD

Study group248.53 ± 43.928.81 ± 0.646.1 ± 4.45
E1E1 : CE1 : CE1 : C
n.s.n.s.n.s.

Study group528.43 ± 326.138.92 ± 0.8214.1 ± 7.61
E2E1 : E2E1 : E2E1 : E2
P < 0.05 * n.s.n.s.

Study group344.28 ± 266.409.48 ± 0.8710.17 ± 8.56
A1 A1 : C A1 : CA1 : C
n.s.P < 0.05 * P < 0.05 *

Study group584.25 ± 237.549.64 ± 0.7920.83 ± 12.43
A2A1 : A2A1:A2A1 : A2
P < 0.05 * n.s.P < 0.05 *

Study group335.84 ± 154.089.04 ± 0.868.16 ± 3.47
M1M1 : C M1 : C M1 : C
P < 0.01 * n.s.P < 0.01 *

Study group451.55 ± 210.749.23 ± 1.1010.27 ± 5.69
M2M1 : M2 M1 : M2M1 : M2
n.s.n.s.n.s.

Control group
C247.78 ± 44.748.68 ± 0.645.34 ± 1.81

Statistically significant when P < 0.05.